Stay updated with breaking news from Doug langa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Senate Committee on Health, Education, Labor, and Pensions has announced that Novo Nordisk CEO Lars Jorgensen will voluntarily testify about the high U.S. prices for weight loss drugs Ozempic and Wegovy. This decision cancels a scheduled vote to subpoena Novo's president Doug Langa. The hearing will discuss why these drugs are significantly more expensive in the U.S. compared to other countries. ....
(Reuters) -The Senate Committee on Health, Education, Labor, and Pensions said on Friday that Novo Nordisk CEO Lars Jorgensen has agreed to testify voluntarily in a hearing focusing on U.S. ....
This week in Other Barks and Bites: the D.C. Court of Appeals finds that the Administrative Procedures Act waives sovereign immunity in the context of copyright rule promulgation; the U.S. Chamber of Commerce calls out Bernie Sanders for abusive subpoenas targeting a pharmaceutical executive at Novo Nordisk; and more. ....
A U.S. Senate health panel vote that was scheduled for its June 18 meeting, to decide whether to subpoena Novo to answer questions about U.S. prices for the blockbuster drugs, is no longer necessary and will be canceled, Senator Bernie Sanders, who chairs the committee, said. The subpoena would have required Novo President Doug Langa to testify at a July 10 hearing. Jorgensen will testify before the committee, and the hearing will be held in early September. ....
A U.S. Senate health panel vote that was scheduled for its June 18 meeting, to decide whether to subpoena Novo to answer questions about U.S. prices for the blockbuster drugs, is no longer necessary and will be canceled, Senator Bernie Sanders, who chairs the committee, said. The subpoena would have required Novo President Doug Langa to testify at a July 10 hearing. Jorgensen will testify before the committee, and the hearing will be held in early September. ....